Werewolf Therapeutics Inc — Cash Flow (NASDAQ:HOWL)

Financials

Cash from operating activities -42.88 M-40.6 M-32.61 M-56.19 M -63.52 M Cash from investing activities -498 K-3.61 M-769 K-254 K -123 K Cash from financing activities 109.43 M15.91 M58.43 M13.08 M 6.21 M Free cash flow -43.37 M-44.21 M-33.38 M-56.44 M -63.64 M

Haberler

Werewolf Therapeutics satış ve stratejik alternatifleri değerlendiriyor

Werewolf Therapeutics explores sale and strategic alternatives

Werewolf Therapeutics hisseleri işgücünün %64’ünü azaltma kararı sonrası düştü

Werewolf Therapeutics stock falls after announcing 64% workforce reduction

Werewolf Therapeutics, Nasdaq’tan minimum teklif fiyatı yetersizliği bildirimi aldı

Werewolf Therapeutics receives Nasdaq notice for minimum bid price deficiency

Evnin Luke, Werewolf Therapeutics director, sells $20,942 in Howl stock

Evnin Luke, Werewolf Therapeutics (HOWL) hisselerini 53.533 dolar karşılığında sattı

Evnin Luke sells Werewolf Therapeutics (HOWL) shares for $53,533

Evnin Luke, Werewolf Therapeutics (HOWL) hisselerini 45.882 dolar karşılığında sattı

Evnin Luke sells Werewolf Therapeutics (HOWL) stock for $45,882

H.C. Wainwright, boru hattı güncellemesi sonrası Werewolf Therapeutics hisse fiyat hedefini düşürdü